SEC Form 4 · accession 0001181431-15-007192
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Javier Rodriguez
Officer — CEO, Kidney Care
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 9:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2015 | A | 72,932 | $0.00 | A | 137,196 | D | |
| Common StockF3 | May 15, 2015 | S | 36,466 | $81.5006 | D | 100,730 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares received upon the satisfaction of performance criteria underlying the awards of performance units.
- F2The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2015.
- F3Represents the weighted average sale price of $81.5006. The range of prices for the sale of these shares was $81.03 - $82.16, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.